Welcome to our dedicated page for Riv Capital news (Ticker: CNPOF), a resource for investors and traders seeking the latest updates and insights on Riv Capital stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Riv Capital's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Riv Capital's position in the market.
RIV Capital announced significant executive changes, appointing Mike Totzke as interim CEO following Mark Sims's departure. The company is forming a Strategic Growth Committee to explore growth strategies, including potential M&A. For FQ3 2023, RIV reported $2.0 million in revenue, with $1.9 million net after excise taxes. Gross profit stood at $0.8 million, while net loss was $9.9 million, showing a rise in operational expenses to $4.8 million. The company holds a solid cash position of $125.6 million. Key initiatives in New York include infrastructure improvements and a revamped wholesale program to enhance growth opportunities.
FAQ
What is the current stock price of Riv Capital (CNPOF)?
